However, semaglutide was not linked to a significantly reduced risk of developing thyroid, stomach, or breast cancer. Yoni Resnick, PharmD, the director of pharmacy clinical services with New ...

it has found no evidence that GLP-1 agonist drugs such as Novo Nordisk’s Ozempic and Eli Lilly’s Trulicity can cause cancer of the thyroid. Six months ago, the Pharmacovigilance Risk ...

Compared with other antidiabetic medications, semaglutide was linked to a significantly lower risk of opioid overdose in ...

GLP-1 receptor agonists like semaglutide were originally developed ... and preclinical studies have raised concerns about a possible risk of thyroid cancer, although this has not yet been observed ...

and increased risk of papillary thyroid cancer in children and young adults up to 19 years old. The exposures occurred during the perinatal stage of life, typically defined as the time from when ...